Abstract
Introduction

Cells of the immune system continually monitor a host for invading pathogens and participate in clearing those pathogens so the body remains free of infection. This active response is an immunogenic response. Under non-infectious conditions, cells of the immune system are also continually exposed to proteins of the host and any immune responses which develop are suppressed so the host maintains a state of self-tolerance. The cells that direct the outcome of pathogen exposure are the antigen-presenting cells (APC), and these include dendritic cells (DC), macrophages and some B lymphocytes. APC continually filter the molecular environment for both host and pathogen proteins. The potential for control of the uptake and presentation of environmental antigens by APC is important for immunotherapy aimed at both the tolerogenic and immunogenic capacity of APC. Achieving therapeutic control over DC could have impact on immunization for pathogens and cancers on the one hand, and immunosuppression for autoimmune diseases and organ transplant rejection on the other. To date, the difficulty has been to determine the conditions under which DC behave in an immunogenic versus a regulatory or suppressive manner. Spleen has been the organ of focus in many
DC studies due to its unique role as a site of DC development [1] [2] [3] . It is also a site for DC exposure to blood-borne pathogens and apoptotic or dying cells [4] . [5] .
The range of murine dendritic cell types
The main function of DC is to endocytose and process antigen from pathogens or apoptotic cells, and to present antigen as peptide in the context of major histocompatibility complex (MHC) Class I and II molecules for T-cell recognition and activation. The outcome of T-cell activation can be either immunity or tolerance depending on the signals that accompany T-cell receptor (TCR) recognition of antigen
Cell [19] . DC tolerogenicity is not therefore a characteristic of a specific subset, or lineage of DC, but a feature of the environmental niche surrounding the developing cell. Indeed, an important characteristic of DC is their functional plasticity and their ability to adopt different APC characteristics depending on the cytokine milieu or inflammation site in which they are located [20] .
The tolerogenic function of dendritic cells
A wealth of evidence now indicates that DC maturation or activation status rather than DC lineage per se determines the immunogenicity of DC
Several environmental factors are well known to support the development of tolerogenic/suppressive DC including the immunosuppressive cytokines IL-10 and transforming growth factor-␤ (TGF-␤), as well as other factors like hepatocyte growth factor, granulocyte colony stimulating factor (G-CSF)
, prostaglandin E2 and histamine [21, 22] [24] . [1, 36, 37] . [20, 35] . These were defined as 'immature' DC expressing CD45RB, isolated directly from BM or induced by culture of BM progenitors with stroma comprising a combination of fibroblastic and endothelial cells [32] . Others 
in the collagen-induced arthritis model in mice, orally induced tolerance due to collagen administration has been associated with pDC and their production of induction of 2,3 indoleamine dioxygenase (IDO) with subsequent formation of Tregs [30]. Tregs then have an inhibitory effect on T-cell proliferation and their production of inflammatory cytokines [30]. Soluble factors produced by tolerogenic DC could represent valuable immunotherapeutic agents for control of T-cell proliferation and activation in autoimmune diseases. Furthermore, both immature and mature pDC can induce tolerogenic responses. Immature pDC induce anergy in CD4 + T cells, and mature pDC can induce regulatory T-cell function in CD8 + T cells [24]. While the induction of CD4 + T-cell anergy by immature pDC is thought to occur through DC-T-cell contact in the absence of costimulatory molecules, the induction of regulatory function in CD8 + T cells by mature pDC may be mediated by the activation of the pDC by CD40L
Regulatory dendritic cells and immunosuppression
Recent evidence also implicates a role for various subsets of murine DC termed 'regulatory' DC (DCreg) in the suppression of T-cell responses. These are listed in
Some authors describe DCregs that can induce the development of Treg cells
